Guanfacine Tablet, Extended Release
Product Images NDC 24979-534

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Guanfacine (NDC 24979-534). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle-label-1-mg.jpg (Bottle Label 1 mg)

Label for Guanfacine Extended-Release Tablets, 1 mg strength, oral extended-release tablets in a 100 count package by Upsher-Smith Laboratories, LLC. The label includes storage instructions, a note for pharmacists to dispense with patient information, and manufacturing details for TWi Pharmaceuticals USA, Inc. and TWi Pharmaceuticals, Inc.*

FDA Label Image

Bottle-label-2-mg.jpg (Bottle Label 2 mg)

Label for Guanfacine Extended-Release 2 mg tablets, oral route, in a 100-tablet package. Label indicates prescription only and includes manufacturer information for Upsher-Smith Laboratories, LLC, and TWi Pharmaceuticals. Dosage form is extended-release tablet with a blue highlighted 2 mg strength on the label.*

FDA Label Image

Bottle-label-3-mg.jpg (Bottle Label 3 mg)

Label for Guanfacine Extended-Release Tablets, 3 mg strength, oral dosage form. The label indicates the package contains 100 tablets. It includes manufacturer information for TWi Pharmaceuticals USA, Inc. and TWi Pharmaceuticals, Inc., as well as storage instructions and a pharmacist dispensing note.*

FDA Label Image

Bottle-label-4-mg.jpg (Bottle Label 4 mg)

Label for Guanfacine Extended-Release Tablets 4 mg by Upsher-Smith Laboratories, LLC, containing 100 tablets. The label includes dosing and storage information, manufacturer details, and a warning that tablets should not be crushed, chewed, or broken before swallowing.*

FDA Label Image

Figure-1.jpg (Figure 1)

A line graph showing guanfacine plasma concentration (ng/mL) over 24 hours. The graph compares Guanfacine Extended-Release Tablets 1 mg QD (solid line with square markers) and Tenex 1 mg QD (dashed line with triangle markers), illustrating concentration changes over time.*

FDA Label Image

Figure-2.jpg (Figure 2)

A pharmacokinetic chart showing fold changes and 90% confidence intervals for Cmax and AUC values of guanfacine extended-release when co-administered with various CYP3A4/5 inhibitors, inducers, and other drugs. The x-axis indicates change relative to reference, and comparisons include ketoconazole, fluconazole, rifampin, efavirenz, oral methylphenidate, and lisdexamfetamine dimesylate.*

FDA Label Image

Figure-3.jpg (Figure 3)

A chart illustrating the fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of oral methylphenidate and lisdexamfetamine dimesylate, showing changes relative to a reference value. The x-axis represents fold change from 0.0 to 2.0, with plotted data points near 1.0.*

FDA Label Image

Figure-4.jpg (Figure 4)

A line graph showing time to treatment failure (days) on the x-axis and treatment failure rate (%) on the y-axis. It compares two groups labeled Placebo (solid line) and SPD603 (dashed line) over approximately 200 days, illustrating differences in treatment failure rates between the groups over time.*

FDA Label Image

Figure-5 (Figure 5)

FDA Label Image

Molecular-structure.jpg (Molecular Structure)

Chemical structure diagram of Guanfacine, showing its molecular components including chlorine atoms and an associated hydrochloride (HCl) group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.